Group One Trading
MYOV

Group One Trading’s Myovant Sciences Ltd. MYOV Stock Holding History

Group One Trading’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-175,700
Closed -$4.74M – 8267
2022
Q4 		$4.74M Buy
175,700
+29,100
+20% +$765K 0.01% 1178
2022
Q3 		$2.63M Buy
146,600
+76,900
+110% +$1.23M 0.01% 1669
2022
Q2 		$866K Sell
69,700
-2,600
-4% -$28.7K ﹤0.01% 2900
2022
Q1 		$963K Buy
72,300
+16,600
+30% +$223K ﹤0.01% 3117
2021
Q4 		$867K Buy
55,700
+25,100
+82% +$479K ﹤0.01% 3504
2021
Q3 		$687K Sell
30,600
-30,700
-50% -$674K ﹤0.01% 3837
2021
Q2 		$1.4M Buy
61,300
+15,900
+35% +$335K ﹤0.01% 3034
2021
Q1 		$934K Sell
45,400
-21,800
-32% -$496K ﹤0.01% 3317
2020
Q4 		$1.86M Buy
67,200
+13,500
+25% +$263K ﹤0.01% 2118
2020
Q3 		$754K Sell
53,700
-18,300
-25% -$340K ﹤0.01% 2461
2020
Q2 		$1.49M Buy
72,000
+39,500
+122% +$537K 0.01% 1684
2020
Q1 		$245K Sell
32,500
-10,000
-24% -$112K ﹤0.01% 2593
2019
Q4 		$660K Buy
+42,500
New +$428K ﹤0.01% 2213

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's MYOV Position: Q3 2022 in Review

Group One Trading sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 10,323 shares — an estimated $165K sold.

Group One Trading first reported a position in MYOV in Q4 2019 and held it in 10 quarters. The position peaked at $674K in Q4 2019. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Group One Trading reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 10,323 Myovant Sciences Ltd. shares in Q3 2022, an estimated $165K.
  • Group One Trading first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 10 quarters.
  • Group One Trading's Myovant Sciences Ltd. position peaked at $674K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.